Juxtapid
Active substance: lomitapide
CAPSULE · LOMITAPIDE MESYLATE 20 mg/1
United StatesActive
Marketing holder: Chiesi USA, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- LOMITAPIDE MESYLATE · 20 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-325d-70d3-99a3-7ffba85ab9ff,01a1208c-f608-7221-a6c4-9d7d40585ac1,01a1208d-c4c2-7380-a155-be75030753ca,01a1208d-f95a-76e8-b3c2-959bfbbb4303,01a1208f-7f41-7d17-bf58-d5a4826e3980;count=7 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 10122-420
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 10122-420 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 10122-420 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 10122-420 · Verified 2026-10-09 · open in source